Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled studyJiao Liu, Dechang Chen, Xian Zhang et al.|The Lancet Regional Health - Western Pacific|2023Cited by 112
Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case–control studyJiao Liu, Dechang Chen, Min Shao et al.|Annals of Intensive Care|2022Cited by 41
Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patientsMei Meng, Dechang Chen, Limin Chen et al.|BMC Infectious Diseases|2021Cited by 21
Association of gut microbiota with COVID‐19 susceptibility and severity: A two‐sample Mendelian randomization studyWeifeng Shang, Dechang Chen, Sheng Zhang et al.|Journal of Medical Virology|2023Cited by 15
Potential Predictors for Disease Progression and Medication Evaluation of 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, ChinaSheng Zhang, Dechang Chen, Jingya Zhao et al.|SSRN Electronic Journal|2020Cited by 6